基因修饰的组织工程骨修复节段性骨缺损及相关免疫学研究
摘要点击次数: 1745   全文下载次数: 1036   投稿时间:2005-02-20    
作者Author单位AddressE-Mail
李建军 LI Jian-jun 中国医科大学附属二院 辽宁沈阳110004 Department of Orthopaedics,the Second Affiliated Hospital of China Medical University,Shenyang 110004,Liaoning,China lijianjun71@yahoo.com.cn 
白伦浩 BAI Lun-hao 中国医科大学附属二院 辽宁沈阳110004 Department of Orthopaedics,the Second Affiliated Hospital of China Medical University,Shenyang 110004,Liaoning,China  
王欢 WANG Huan 中国医科大学附属二院 辽宁沈阳110004 Department of Orthopaedics,the Second Affiliated Hospital of China Medical University,Shenyang 110004,Liaoning,China  
徐莘香 XU Xin-xiang 吉林大学第一医院骨科  
期刊信息:《中国骨伤》2005年,第18卷,第10期,第601-603页
DOI:doi:10.3969/j.issn.1003-0034.yyyy.nn.zzz
基金项目:国家自然科学基金项目(39800151);;吉林省科技厅基金项目(20010110)
中文摘要:

目的:观察骨形态发生蛋白-2(BMP-2)基因修饰的组织工程骨修复节段性骨缺损效果及异种骨支架体内应用的安全性。

方法:①制备去抗原牛松质骨块(BCB),植入小鼠股四头肌袋内,术后行淋巴细胞转化试验和组织学观察。②在腺病毒载体介导下将BMP-2基因导入兔骨髓间质干细胞后,种植到BCB支架中,构建基因修饰的组织工程骨。于兔双侧桡骨中段造成15mm骨缺损,采用5种方法进行处理BMP-2基因转染细胞+BCB(A组);未转染细胞+重组BMP-2+BCB(B组);对照基因转染细胞+BCB(C组);未转染细胞+BCB(D组);单纯BCB(E组)。术后4、8、12周行X线、组织学和生物力学检测。

结果:①BCB具有较低的抗原性和良好的组织相容性;②A组术后4周诱导生成软骨组织并向编织骨转化,12周骨缺损修复,髓腔再通,新骨强度明显优于其他各组(P<0.01)。

结论:BMP-2基因修饰的组织工程骨是修复节段性骨缺损的好方法。
【关键词】骨形态发生蛋白质类  基因疗法  组织工程  骨再生  免疫学
 
Study of repairing segmental bone defects by using gene modified tissue engineering bone
ABSTRACT  

Objective: To observe the effects of BMP-2 gene modified tissue engineering bone in the treatment of segmental bone defects and the safety of xenogenetic scaffolds in vivo.

Methods:①Antigen-free bovine cancellous bone (BCB) was prepared and implanted into the quadriceps femoris of mice.Lymphocytes proliferation assay and histological observation were done after operation.②The rabbit bone mesenchymal stem cells (BMSC) were transfected by BMP-2 gene which mediated by adenovirus vector (Ad-BMP-2),then was seeded on the BCB scaffolds to create gene modified tissue engineering bone.Bone defects of 15 mm were created on the bilateral radius of rabbits and treated with five kinds of implantations:Ad-BMP-2 infected BMSC with BCB (Group A);BMSC-BCB with recombined hBMP-2 (Group B);Ad-Lacz infected BMSC-BCB(Group C);BMSC-BCB(Group D) and only BCB scaffolds (Group E).After 4,8,and 12 weeks of the operations,X-ray,histological examination and biomechanics analysis were conducted.

Results:①BCB had low antigenicity and fine histocompatibility;②In group A,cartilage formation was observed and transformed into woven bone after 4 weeks.Bone defects healed and marrow cavity opened again after 12 weeks.The new bone strength was obviously superior to that of other groups (P<0.01).

Conclusion:BMP-2 gene modified tissue engineering bone is good to repair segmental bone defects.
KEY WORDS  Bone morphogenetic protein  Gene therapy  Tissue engineering  Bone regeneration  Immunology
 
引用本文,请按以下格式著录参考文献:
中文格式:李建军,白伦浩,王欢,徐莘香.基因修饰的组织工程骨修复节段性骨缺损及相关免疫学研究[J].中国骨伤,2005,18(10):601~603
英文格式:LI Jian-jun,BAI Lun-hao,WANG Huan,XU Xin-xiang.Study of repairing segmental bone defects by using gene modified tissue engineering bone[J].zhongguo gu shang / China J Orthop Trauma ,2005,18(10):601~603
阅读全文  下载  查看/发表评论  下载PDF阅读器
关闭




版权所有:《中国骨伤》杂志社京ICP备12048066号-2  版权声明
地址:北京市东直门内南小街甲16号,100700
电话:010-64089487 传真:010-64089792 Email:zggszz@sina.com

京公网安备 11010102004237号